NanoMedicine Technology Platform

NanoMedicine Technology Platform

Genetic Immunity's immune amplification platform technology is used to develop nanomedicines comprised of two principal components, NanoComp and DermaPrep, which are designed to work together to treat and/or control chronic diseases. These components in combination make up the DermaVir Patch which is the Company's lead nanomedicine candidate.

  • NanoComp: Antigen composition platform combining a disease specific plasmid DNA with Genetic Immunity's nanoparticle formulation technology
  • DermaPrep: Topical administration device for delivering NanoComp into lymph node dendritic cells

DermaVir Patch: Topical nanomedicine for the treatment of HIV/AIDS containing NanoComp nanoparticles and delivered via the DermaPrep device


  
 
 


Search 
By Google on This Site Web
Events Calendar
Site MapLast Update: January 3, 2009